Currently, AUD has only three FDA-approved drug treatments: acamprosate disulfiram naltrexone The JAMA Psychiatry study builds on evidence suggesting that GLP-1 drugs could help treat AUD
Reierson makes a good point: If these supplements really did help people lose 20, 30, 40 pounds, they would be flying off the shelves
The microdose schedule provides detailed frameworks for this approach
For example, bariatric surgery, which has been around for decades, also works by resetting hormone signaling more than it does caloric restriction
Synthetic comparison of the 3 neuropeptides available from French Peptides, classified by mechanism, neurological target and action profile
FDA Adverse Event Reporting System (FAERS) data similarly do not suggest a pattern of treatment-emergent hypogonadism attributable to semaglutide